Chemoradiation for Rectal Cancer: Rationale, Approaches, and Controversies
- 1 October 2010
- journal article
- review article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 19 (4) , 803-818
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03Journal of Clinical Oncology, 2009
- Magnetic Resonance Imaging Prediction of an Involved Surgical Resection Margin in Low Rectal CancerDiseases of the Colon & Rectum, 2009
- Irinotecan Fluorouracil Plus Leucovorin Is Not Superior to Fluorouracil Plus Leucovorin Alone As Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803Journal of Clinical Oncology, 2007
- Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: Results of study CAO/ARO/AIO-94International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Tumor vascularity evaluated by transrectal color Doppler US in predicting therapy outcome for low-lying rectal cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Capecitabine as Adjuvant Treatment for Stage III Colon CancerNew England Journal of Medicine, 2005
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerNew England Journal of Medicine, 2004
- Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon CancerNew England Journal of Medicine, 2004
- Impact of Hospital Procedure Volume on Surgical Operation and Long-Term Outcomes in High-Risk Curatively Resected Rectal Cancer: Findings From the Intergroup 0114 StudyJournal of Clinical Oncology, 2004
- Effective Surgical Adjuvant Therapy for High-Risk Rectal CarcinomaNew England Journal of Medicine, 1991